OakLabs GmbH is a privately held company founded in 2011 to deliver the most advanced R&D solutions through the combination of highly efficient detection methods with in-silico modeling processes which shorten long lasting R&D efforts at materially
Major shareholders are the two founders Martina Schad, Ph.D., and Jim Kallarackal, Ph.D., and the German High-Tech Gründerfonds (HTGF). The founders are experts in molecular biology and quantum physics and act as CEO and Managing Director.
OakLabs' team of biologists, chemists, mathematicians, quantum physicists and biostatisticians has extensive experience supporting successful research and discovery projects.
OakLabs offers comprehensive services and contract research for industrial and academic research in the fields of biomarker discovery, gene expression analysis, advanced biocomputing, and software development.